VentureBlick Discovery
AI-Guided Neuraxial Ultrasound Positioning Tool - Seeking Experts in France, Germany and Netherlands image
Applications Open

AI-Guided Neuraxial Ultrasound Positioning Tool - Seeking Experts in France, Germany and Netherlands

  • 요금상세 정보를 확인하려면 Expert로 등록해주세요
  • 프로젝트 기간2월 28, 2025 - 5월 30, 2025
  • 전문 분야
    AnaesthesiologyCritical Care
  • 국가
    독일프랑스
  • 문의VentureBlick Singapore (startup.relations@ventureblick.com)

Project Brief

The start-up is a medtech company dedicated to advancing the safety and effectiveness of neuraxial anaesthesia procedures. Founded by a team of clinicians and engineers, this startup focuses on developing user-friendly, AI-driven solutions that help reduce the guesswork and variability associated with spinal and epidural anaesthesia. With a commitment to continuous clinical validation, this start-up aims to provide cost-effective, high-precision tools that support anaesthesiologists, pain management specialists, and perioperative care teams worldwide.

Overview of the Technology

The solution consists of two core components: an AI-driven ultrasound guidance system and an assisted positioning and marking system.

  • Ultrasound Guidance System: AI-powered software that identifies key spinal landmarks such as the interspinous space, midline, and estimated epidural depth. It integrates with various ultrasound machines and provides real-time annotations to improve procedural efficiency and success rates.

  • Positioning and Marking System: A supplementary tool that translates ultrasound-guided entry points and angles onto the patient’s skin. This system records probe angle and indentation during scanning and includes a sterile needle guide for accurate insertion. By capturing both position and angle, it provides a reproducible reference for needle trajectory, reducing reliance on manual techniques.

Regulatory Status & Clinical Validation

The technology has achieved regulatory approval in key markets, including CE Mark certification in Europe. Initial clinical adoption has yielded promising results, with peer-reviewed studies indicating improvements such as:

  • Higher first-pass success rates: Reduced needle redirections and overall attempts, particularly in challenging patient groups (e.g., obese, elderly).

  • Accelerated learning curve: AI-assisted guidance supports trainees in developing competency with neuraxial ultrasound imaging.

  • Reduction in complications: Lower incidence of accidental dural punctures, post-dural puncture headaches, and patient discomfort.

Medical Experts Specialties:

Anaesthesiologists (of various seniorities)

Physicians (ICU, emergency, pain management) who use or could use neuraxial anaesthesia.  

Experience:

  • Minimum of 10 years in clinical practice

Industry Experts Specialties:

  • Commercialization

  • Market access

  • Reimbursement

Experience:

  • Minimum of 10 years in ultrasound field specializing in market entry, commercialization, or regulatory roles within multinational corporations (MNCs)

Geographical Focus Key Regions: Germany, Netherlands and France

Purpose of this Interview / Questionnaire 

Map Current Clinical Practice 

  • Understand how anaesthesiologists, pain specialists, and perioperative care teams currently perform neuraxial blocks, including the use of ultrasound guidance (if any). 

  • Identify pain points, unmet needs, and workflow challenges in delivering epidural or spinal anaesthesia. 

    Gather Product Feedback 

  • Obtain perspectives on how product can integrate into existing clinical workflows. 

  • Explore essential features, user-interface needs, training requirements, and potential barriers to adoption. 

  • Collect expert opinions on how best to demonstrate clinical and economic value. 

    Discuss Commercial Opportunities 

  • Explore pathways for distribution partnerships, hospital-based product trials, and potential collaborations with training centers. 

  • Gain insights on country-specific reimbursement models and decision-making processes in hospital procurement. 

  • Shape a launch strategy that aligns with local purchasing habits, regulatory frameworks, and clinical priorities. 

Interview: Advisors will provide feedback through an interview with VentureBlick team consisting of approximately 25-30 open-ended and rating questions focused on market potential, usability, and clinical impact.

Estimated Time Commitment: 1 hour call and an additional 30-45 minutes to review materials prior to the call

Compensation: $200 USD per hour